Docebo Inc. (NASDAQ:DCBO – Get Free Report) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 193,500 shares, a growth of 6.4% from the August 31st total of 181,900 shares. Currently, 1.4% of the company’s shares are sold short. Based on an average daily volume of 71,600 shares, the days-to-cover ratio is currently 2.7 days.
Docebo Stock Performance
NASDAQ:DCBO traded down $0.11 during mid-day trading on Tuesday, hitting $44.09. The stock had a trading volume of 24,453 shares, compared to its average volume of 96,185. Docebo has a 52 week low of $33.81 and a 52 week high of $56.41. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $1.33 billion, a price-to-earnings ratio of 200.91 and a beta of 1.55. The company has a 50 day simple moving average of $41.84 and a 200-day simple moving average of $41.66.
Docebo (NASDAQ:DCBO – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.01). Docebo had a net margin of 8.56% and a return on equity of 29.82%. The business had revenue of $53.05 million for the quarter, compared to the consensus estimate of $52.30 million. On average, research analysts expect that Docebo will post 0.79 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on Docebo
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of DCBO. Aristides Capital LLC purchased a new position in Docebo during the 2nd quarter valued at about $277,000. Point72 Asset Management L.P. acquired a new position in Docebo in the 2nd quarter valued at approximately $189,000. The Manufacturers Life Insurance Company increased its stake in Docebo by 0.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 196,588 shares of the company’s stock valued at $7,581,000 after buying an additional 1,058 shares during the period. Millennium Management LLC lifted its position in Docebo by 43.0% in the 2nd quarter. Millennium Management LLC now owns 179,685 shares of the company’s stock worth $6,940,000 after buying an additional 54,057 shares in the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of Docebo by 196.3% during the 2nd quarter. Marshall Wace LLP now owns 142,507 shares of the company’s stock valued at $5,505,000 after buying an additional 94,414 shares during the period. 53.17% of the stock is owned by institutional investors and hedge funds.
Docebo Company Profile
Docebo Inc operates as a learning management software company that provides artificial intelligence (AI)-powered learning platform in North America and internationally. It offers Learning Management System (LMS) to train internal and external workforces, partners, and customers. The company's cloud platform consists of a learning suite, which includes Docebo Learn LMS, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Shape, an AI-based learning content creation tool, which enables learning administrators to turn internal and external resources into engaging, multilingual, and microlearning content to share across the business; Docebo Content that allows off-the-shelf learning content by partnering content specialist; Docebo Learning Impact, a learning measurement tool that enables administrators to prove and improve training programs; Docebo Learn Data, which gives a comprehensive view on learning data to business results; Docebo Connect that connects Docebo to custom tech stack and making integrations; and Docebo Flow that allows businesses to directly inject learning into the flow of work.
Further Reading
- Five stocks we like better than Docebo
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Are Penny Stocks a Good Fit for Your Portfolio?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Docebo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docebo and related companies with MarketBeat.com's FREE daily email newsletter.